3 Medical Services Stocks To Buy In 2019: HQY, AMEH & OPGN
Zacks Investment Research | Jan 11, 2019 07:52AM ET
The U.S. the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here .
Our research shows that stocks with a Momentum Score of A or B, when combined with a Zacks Rank #1 or 2, are better picks than most.
Our first pick is HealthEquity, Inc. (NASDAQ:HQY) which has a Momentum Score of A.
The Utah-based healthcare services provider’s fourth-quarter earnings growth rate is projected at a whopping 233.3%.
HealthEquity is an Internal Revenue Service approved non-bank custodian of HSA, which is a medical savings account available to taxpayers in the United States. Interestingly, it has clinched the top position in the HSA (Health Savings Account) industry through its first-mover advantage, focus on innovation and differentiated capabilities.
Additionally, for 2019, HealthEquity projects revenues of $281-$285 million, up from $279-$285 million anticipated earlier.
Next on our list is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) having a Momentum Score of A.
The California-based provider of healthcare services offers integrated care, inpatient and physician alignment solutions. The company’s data-enabled clinical platform provides care for patients continuously, whether they are in the hospital, in a skilled nursing facility or at home.
The company recently announced that its wholly-owned subsidiary, APA ACO, generated $12.96 million in gross savings in the first performance year (2017) and that, as a result, it achieved $5.90 million in shared savings from the Centers for Medicare & Medicaid Services.
Investors may also consider OpGen, Inc. (NASDAQ:OPGN) which has a Momentum Score of B.
The Maryland-based microbial genetics analysis company’s fourth-quarter earnings growth rate is projected at 68.4%.
The company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture.
Last month, the company announced the submission of the final report for completion of the contract from the Centers for Disease Control and Prevention to develop smartphone-based clinical decision support solutions for antimicrobial stewardship and infection control in low and middle-income countries.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Get The News You Want
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.